PBEvsIBBETF Comparison
VS
Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. iShares Biotechnology ETF (IBB) is part of the US Health Care segment. PBE's top 1 sector exposures are Healthcare. In contrast, IBB's top sector exposures are Healthcare, Non-Corporate and Non-Energy Materials. PBE is more expensive with a Total Expense Ratio (TER) of 0.59%, versus 0.44% for IBB. PBE is up 14.59% year-to-date (YTD) with +$114M in YTD flows. IBB performs better with 20.29% YTD performance, and +$363M in YTD flows. Run a side-by-side ETF comparison of PBE and IBB below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PBE vs IBB performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PBE IBB | -0.70%+1.54% | +12.83%+19.02% | +14.59%+20.29% | +35.63%+41.46% | +57.51%+60.28% | +23.66%+20.74% |
| Flows | PBE IBB | +$44M+$288M | +$117M+$782M | +$114M+$363M | +$113M+$1.85B | +$62M-$558M | +$64M-$1.34B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PBE IBB | +19.58%+24.01% | +19.33%+21.76% | +20.48%+21.05% | +22.57%+22.47% |
| Max drawdown | PBE IBB | -5.73%-6.57% | -11.70%-9.61% | -22.21%-24.82% | -33.32%-38.96% |
| Max drawdown duration | PBE IBB | 7d23d | 166d151d | 324d377d | 1509d1523d |
Trading data
PBE | IBB | |
Last sale 9/11/2026 at 1:30 PM | $92.91 | $202.93 |
| Previous close 09/10/2026 | $93.03 | $202.64 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PBE | IBB | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
PBE | IBB | |
|---|---|---|
| Last price | $92.91 | $202.93 |
| 1D performance | -0.13% | +0.14% |
| AuM | $405.87 M | $10.34 B |
| E/R | 0.59% | 0.44% |
Advertisement
Exposure
Countries
PBE
USA
97.13%
Other
2.87%
IBB
USA
86.04%
Other
13.96%
Sectors
PBE
Healthcare
100%
Other
0%
IBB
Healthcare
99.83%
Other
0.17%
Advertisement
Diversification
PBE
Total weight of top 15 holdings out of 15
61.32%
IBB
Total weight of top 15 holdings out of 15
54.48%
Top 15 holdings
Data as of July 31, 2026
PBE
Amgen, Inc.
5.16%
Vertex Pharmaceuticals, Inc.
4.96%
Royalty Pharma Plc
4.91%
Regeneron Pharmaceuticals, Inc.
4.90%
Biogen, Inc.
4.85%
Gilead Sciences, Inc.
4.44%
Alnylam Pharmaceuticals, Inc.
4.34%
United Therapeutics Corp.
4.06%
CareDx, Inc.
4.01%
Bio-Techne Corp.
3.66%
Illumina, Inc.
3.27%
Vericel Corp.
3.25%
Protagonist Therapeutics, Inc.
3.24%
Incyte Corp.
3.19%
Veracyte, Inc.
3.07%
IBB
Amgen, Inc.
8.42%
Vertex Pharmaceuticals, Inc.
7.87%
Gilead Sciences, Inc.
7.14%
Regeneron Pharmaceuticals, Inc.
5.84%
argenx SE
3.55%
Natera, Inc.
2.88%
Revolution Medicines, Inc.
2.87%
Illumina, Inc.
2.42%
Biogen, Inc.
2.38%
Alnylam Pharmaceuticals, Inc.
2.14%
BeOne Medicines Ltd.
2.01%
Incyte Corp.
1.91%
Insmed, Inc.
1.71%
United Therapeutics Corp.
1.69%
Moderna, Inc.
1.65%
Frequently asked questions about PBE and IBB
How have the PBE and IBB ETFs performed in 2026?
As of September 10, 2026, PBE is up 14.59% year-to-date (YTD), while IBB has returned 20.29%. That puts IBB better performer ahead so far this year.
Which ETF is attracting more investor money: PBE or IBB?
Year-to-date, the PBE ETF saw +$114M in flows, compared to +$363M for IBB.
Which ETF is more volatile: PBE or IBB?
Over the past year, PBE had a volatility of 19.33%, while IBB experienced 21.76%.
Which ETF is bigger: PBE or IBB?
As of September 10, 2026, PBE holds $405.87 M in assets under management (AUM), while IBB manages $10.34 B.
What sectors do the PBE and IBB ETFs invest in?
PBE leans toward sectors like Healthcare. Meanwhile, IBB focuses on Healthcare.
What are the top holdings of the PBE ETF and IBB ETF?
PBE top holdings include Amgen, Inc., Vertex Pharmaceuticals, Inc. and Royalty Pharma Plc. IBB holds in its top three: Amgen, Inc., Vertex Pharmaceuticals, Inc. and Gilead Sciences, Inc..
Which ETF is more diversified: PBE or IBB?
PBE holds 30 securities with 61.32% of its assets in the top 15. IBB has 241 securities and a top 15 weight of 54.48%.
Advertisement
Latest news about PBE & IBB
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
September 18, 2025
IBB
Are Biotechnology ETFs In the Midst of a Comeback?
August 20, 2025
IBB
Investing in the Aging Population: A Look at Bonds and Pharma ETFs
March 27, 2023
IBB
Health is Wealth: A look at the Healthcare Sector
January 24, 2023
IBB
Advertisement
Biotech ETFs – Investing in Health Innovation
July 21, 2022
IBB
Biotech ETFs – Investing in Health Innovation
July 21, 2022
IBB
Advertisement
